Changing diagnostic criteria for gestational diabetes (CDC4G) in Sweden: A stepped wedge cluster randomised trial
Maryam de Brun(Örebro University), Helena Backman(Örebro University), Stefan Jansson(Örebro University), Anna‐Karin Wikström(Uppsala University), Elisabeth Storck‐Lindholm(Karolinska University Hospital), Verena Sengpiel(Sahlgrenska University Hospital), David Simmons(Western Sydney University), Ulla‐Britt Wennerholm(Sahlgrenska University Hospital), Kerstin Berntorp(Malmö University), Karin Hildén(Örebro University), Linda Ryen(Örebro University), Helena Strevens(Lund University), Martina Persson(Karolinska Institutet), Fredrik Ahlsson(Uppsala University), Erik Schwarcz(Örebro University), Snehal Patil(University of Michigan), Carina Ursing(Stockholm South General Hospital), Scott Montgomery(Örebro University), Kerstin Petersson(Stockholm South General Hospital), Anders Magnuson(Örebro University)
Cited by 15
Related Papers
Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review
|Diabetic Medicine|2011|355
Discovery and prioritization of variants and genes for kidney function in >1.2 million individuals
|Nature Communications|2021|331
Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial
|The Lancet Diabetes & Endocrinology|2020|228
Effect of physical activity and/or healthy eating on GDM risk: The DALI Lifestyle Study
|The Journal of Clinical Endocrinology & Metabolism|2016|224